Additionally, research from Harvard Medical School and Brigham and Womens Hospital indicates that as the use of GLP-1 medications increase, there is a decline in bariatric surgeries (a collection of procedures that modify the digestive system to help people lose weight
See availability The latest news, articles, and resources, sent to your inbox weekly.
Nausea, vomiting, and diarrhea are particularly common when starting treatment or during dose increases, but these symptoms typically improve over time for most patients
With the rapid rise in use of medications like semaglutide and tirzepatide, its reasonable to ask not only what they do for weight and blood sugar, but also how they affect mood, emotions, and the brain
Also GLP1RAs have been found to decrease epicardial fat, which may help explain their potential in lowering the risk of atherosclerosis
Al-Majed AA, et al